Not Signed In -
Candesartan |
Atacand; candesartan cilexetil |
Candesartan Systematic (IUPAC) name 3-((2'-(2H-tetrazol-5-yl) biphenyl-4-yl)methyl)-2-ethoxy- 3H-benzo[d]imidazole-4-carboxylic acid Identifiers CAS number 139481-59-7 ATC code C09CA06 PubChem 2541 DrugBank APRD00420 Chemical data Formula C24H20N6O3 Mol. weight 440.45 Pharmacokinetic data Bioavailability 15% (candesartan cilexetil) Metabolism Candesartan cilexetil: intestinal wall; candesartan: hepatic (CYP2C9) Half life 5.1–10.5 hours Excretion Renal 3 ...
Wikipedia - [full article]
Resources
- Atacand (Drug Digest)
- Atacand Consumer Information (U.S. Food and Drug Administration)
Candesartan News Headlines
- Incidence Of Atrial Fibrillation Significantly Reduced By Candesartan Therapy In Heart Failure Patients
MedicalNewsToday - Sun, 16 Jul 2006 06:00 EST
- Incidence Of Atrial Fibrillation Significantly Reduced By Atacand® Therapy In Heart Failure Patients
MedicalNewsToday - Mon, 10 Jul 2006 06:00 EST
- Novel Study Published In New England Journal Of Medicine Evaluates Effects Of ATACAND(R) (candesartan Cilexetil) In Patients With Prehypertension
MedicalNewsToday - Fri, 21 Apr 2006 06:00 EST
- Candesartan therapy can reduce the risk of diabetes in heart failure patients
MedicalNewsToday - Sun, 10 Jul 2005 08:00 EST
- Cardesartan Helps Improve Subjective Symptoms in Heart Failure Patients, Large-Scale CHARM Study
MedicalNewsToday - Tue, 07 Jun 2005 10:00 EST
- Heart failure patients perceive improvement in symptoms on Atacand® treatment
MedicalNewsToday - Sat, 04 Jun 2005 05:00 EST
- First large-scale international clinical programme for treatment of diabetic retinopathy
MedicalNewsToday - Wed, 01 Jun 2005 06:00 EST
- FDA Approves Atacand for Use with an ACE Inhibitor in the Treatment of Heart Failure
MedicalNewsToday - Sun, 22 May 2005 01:00 EST
email this page
print this page
bookmark this page
feedback on this page
